Evidence for a role of adverse sarcomere signaling in atrial fibrillation induction. [PDF]
McCauley MD, Solaro RJ.
europepmc +1 more source
Myosin inhibitor therapy in Fabry cardiomyopathy with dynamic left ventricular outflow obstruction. [PDF]
Lau K, Petri N, Nordbeck P.
europepmc +1 more source
Septal reduction therapy in obstructive hypertrophic cardiomyopathy: contextualizing outcomes in an era of cardiac myosin inhibition. [PDF]
Govind A.
europepmc +1 more source
Dapagliflozin Prevents Heart Failure With Preserved Ejection Fraction by Inhibiting the Sodium/Hydrogen Exchanger. [PDF]
Liu M +7 more
europepmc +1 more source
Left Ventricular Structural, Physiological, and Transcriptomic Abnormalities in a Novel Porcine Hypertrophic Cardiomyopathy Model. [PDF]
Green EM +20 more
europepmc +1 more source
Sotagliflozin corrects myocardial phenotype, mitochondrial gene expression and oxidative stress in mice with hypertrophic cardiomyopathy. [PDF]
Qin F +6 more
europepmc +1 more source
Multi-omics insight into cardiac myofibril remodeling in post-prandial Burmese pythons. [PDF]
Martin TG +14 more
europepmc +1 more source
Authors' response: septal reduction therapy for obstructive hypertrophic cardiomyopathy. [PDF]
Schelldorfer A, Kutz A, Yakupoglu HY.
europepmc +1 more source
Immature and mature myocardium in the pathophysiology of hypertrophic cardiomyopathy. [PDF]
Federspiel JM +5 more
europepmc +1 more source
Comparative Strain Trajectories After Septal Myectomy, Alcohol Septal Ablation, and Myosin Inhibitor Therapy. [PDF]
Hwang IC +15 more
europepmc +1 more source

